New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export AMGN’s income statement to Excel — free account
Amgen Inc.
AMGNHealthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.
- Revenue
- +8.45%
- EPS
- +19.4%
- Free cash flow
- −14.0%
- Total debt
- −1.06%
Quarter to September 2026, against a year earlier
439.16
0.36
+0.08%
Follow AMGN
Alert me
Amgen Inc. 10-K filed Feb 14, 2025
What changed
Item 1A, Risk Factors: no comparison — no earlier filing on file